NEBALOC (Pharmacor Pty Ltd)
Product name
NEBALOC
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
146 (255 working days)
Active ingredients
nebivolol hydrochloride
Registration type
New generic medicine
Indication
NEBALOC is indicated:
- To treat essential hypertension;
- To treat stable chronic heart failure as an adjunct to standard therapies in patients 70 years or older.